Minerva Neurosciences Inc

XNAS:NERV  
3.88
-0.20 (-4.90%)
7:50:43 PM EDT: $3.81 -0.07 (-1.80%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Minerva Neurosciences Inc Stock, XNAS:NERV

1500 District Avenue, Suite 286, Burlington, Massachusetts 01803
United States of America
Phone: +1.617.600.7373
Number of Employees: 8
http://www.minervaneurosciences.com

Description

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson�s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.